DTB Select: 11 | November 2013
Identifieur interne : 001140 ( Main/Exploration ); précédent : 001139; suivant : 001141DTB Select: 11 | November 2013
Auteurs :Source :
- Drug and Therapeutics Bulletin [ 0012-6543 ] ; 2013-11.
English descriptors
- Teeft :
- Annualised exacerbation rates, Antibiotic, Antibiotic exposure, Antibiotic treatment, Bladder cancer, Breast cancer, Cardiovascular, Cardiovascular death, Cardiovascular outcomes, Care excellence, Copd, Dapagliflozin, Diabetes, Exacerbation, Guideline, Healthcare professionals, Heart failure, Indacaterol, Inhibitor, Intermittent regimens, Large randomised, Lower limit, Lung function, Malaria prevention, Microbial preparation group, Multicentre trial, Myocardial infarction, National institute, November, Other antidiabetic drugs, Other treatments, Placebo, Placebo group, Plasmodium, Plasmodium falciparum, Primary endpoint, Randomised, Saxagliptin, Saxagliptin group, Scottish medicines consortium, Secondary endpoint, Severe copd, Sglt2 inhibitors, Single agent, Statin, Statin intolerance, Supplementary prescribers, Systematic review, Tiotropium.
Abstract
Every month, DTB scans sources of information on treatments, disease management and other healthcare topics for key items to bring to our readers' attention and help them keep up to date. To do this, we produce succinct, contextualised summaries of the information concerned. We also include comments on, for example, the strengths of the information, whether it contains anomalies, ambiguities, apparent error or omissions, or whether or how it affects current practice.
Url:
DOI: 10.1136/dtb.2013.11.0213
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002651
- to stream Istex, to step Curation: 002651
- to stream Istex, to step Checkpoint: 000192
- to stream Main, to step Merge: 001141
- to stream Main, to step Curation: 001140
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>DTB Select: 11 | November 2013</title></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:81CFEDF62DA27A7554FCF77CF279A8681FD3CE1F</idno><date when="2013" year="2013">2013</date><idno type="doi">10.1136/dtb.2013.11.0213</idno><idno type="url">https://api.istex.fr/ark:/67375/NVC-6BJPDSNL-4/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">002651</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002651</idno><idno type="wicri:Area/Istex/Curation">002651</idno><idno type="wicri:Area/Istex/Checkpoint">000192</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000192</idno><idno type="wicri:Area/Main/Merge">001141</idno><idno type="wicri:Area/Main/Curation">001140</idno><idno type="wicri:Area/Main/Exploration">001140</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">DTB Select: 11 | November 2013</title></analytic><monogr></monogr><series><title level="j">Drug and Therapeutics Bulletin</title><title level="j" type="abbrev">DTB</title><idno type="ISSN">0012-6543</idno><idno type="eISSN">1755-5248</idno><imprint><publisher>BMJ Publishing Group Ltd</publisher><date type="published" when="2013-11">2013-11</date><biblScope unit="volume">51</biblScope><biblScope unit="issue">11</biblScope><biblScope unit="page" from="122">122</biblScope></imprint><idno type="ISSN">0012-6543</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0012-6543</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Annualised exacerbation rates</term><term>Antibiotic</term><term>Antibiotic exposure</term><term>Antibiotic treatment</term><term>Bladder cancer</term><term>Breast cancer</term><term>Cardiovascular</term><term>Cardiovascular death</term><term>Cardiovascular outcomes</term><term>Care excellence</term><term>Copd</term><term>Dapagliflozin</term><term>Diabetes</term><term>Exacerbation</term><term>Guideline</term><term>Healthcare professionals</term><term>Heart failure</term><term>Indacaterol</term><term>Inhibitor</term><term>Intermittent regimens</term><term>Large randomised</term><term>Lower limit</term><term>Lung function</term><term>Malaria prevention</term><term>Microbial preparation group</term><term>Multicentre trial</term><term>Myocardial infarction</term><term>National institute</term><term>November</term><term>Other antidiabetic drugs</term><term>Other treatments</term><term>Placebo</term><term>Placebo group</term><term>Plasmodium</term><term>Plasmodium falciparum</term><term>Primary endpoint</term><term>Randomised</term><term>Saxagliptin</term><term>Saxagliptin group</term><term>Scottish medicines consortium</term><term>Secondary endpoint</term><term>Severe copd</term><term>Sglt2 inhibitors</term><term>Single agent</term><term>Statin</term><term>Statin intolerance</term><term>Supplementary prescribers</term><term>Systematic review</term><term>Tiotropium</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Every month, DTB scans sources of information on treatments, disease management and other healthcare topics for key items to bring to our readers' attention and help them keep up to date. To do this, we produce succinct, contextualised summaries of the information concerned. We also include comments on, for example, the strengths of the information, whether it contains anomalies, ambiguities, apparent error or omissions, or whether or how it affects current practice.</div></front></TEI><affiliations><list></list><tree></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001140 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001140 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:81CFEDF62DA27A7554FCF77CF279A8681FD3CE1F
|texte= DTB Select: 11 | November 2013
}}
| This area was generated with Dilib version V0.6.33. |  |